Literature DB >> 12660596

[Optic nerve sheath decompression in optic neuropathy complicating idiopathic intracranial hypertension: a new focus].

M A Villain1, E Candon, B Arnaud, H Hamard, J-P Adenis.   

Abstract

Optic nerve sheath decompression is a surgical procedure only used in optic neuropathy complicating idiopathic intracranial hypertension. We describe this technique and compare it with the classic technique of cerebrospinal liquid derivation. Several points contrast optic nerve sheath decompression and cerebrospinal fluid derivation: there is no biomaterial, it is limited to the orbital area, and intracranial pressure remains unchanged. The complications are different, yet analysis of the literature shows the same efficacy in terms of visual function. We recommend a practical management of optic neuropathy complicating idiopathic intracranial hypertension, depending on the functional severity and the therapeutic efficacy. The surgical indication should only concern serious optic neuropathy not responding to medical therapy, with the choice of the surgical technique belonging to the surgeon.

Entities:  

Mesh:

Year:  2003        PMID: 12660596

Source DB:  PubMed          Journal:  J Fr Ophtalmol        ISSN: 0181-5512            Impact factor:   0.818


  3 in total

1.  Optic Nerve Sheath Meningocele: A Case Report.

Authors:  E Halimi; O Wavreille; R Rosenberg; I Bouacha; J-P Lejeune; S Defoort-Dhellemmes
Journal:  Neuroophthalmology       Date:  2013-03-22

2.  Ultrasonography of the optic nerve sheath may be useful for detecting raised intracranial pressure after severe brain injury.

Authors:  Thomas Geeraerts; Yoann Launey; Laurent Martin; Julien Pottecher; Bernard Vigué; Jacques Duranteau; Dan Benhamou
Journal:  Intensive Care Med       Date:  2007-08-01       Impact factor: 17.440

3.  Non-invasive assessment of intracranial pressure using ocular sonography in neurocritical care patients.

Authors:  Thomas Geeraerts; Sybille Merceron; Dan Benhamou; Bernard Vigué; Jacques Duranteau
Journal:  Intensive Care Med       Date:  2008-05-29       Impact factor: 17.440

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.